Savaysa (edoxaban tablets) — Cigna
Treatment or Prevention of Other Thromboembolic-Related Conditions
Initial criteria
- Patient age ≥ 18 years
- Patient meets ONE of the following (i or ii):
- i. Patient has tried warfarin, fondaparinux, or a low molecular weight heparin product (e.g., enoxaparin, Fragmin [dalteparin injection])
- ii. Patient has been started on Savaysa for the treatment of an acute thromboembolic condition
Approval duration
6 months